Highlights and Quick Summary
- R&D Expenses for the quarter ending June 30, 2023 was $17.1 Million (a 8.48% increase compared to previous quarter)
- Year-over-year quarterly R&D Expenses increased by 19.3%
- Annual R&D Expenses for 2022 was $48.6 Million (a 96.19% increase from previous year)
- Annual R&D Expenses for 2021 was $24.8 Million (a 308.88% increase from previous year)
- Annual R&D Expenses for 2020 was $6.06 Million (a 266.38% increase from previous year)
- Twelve month R&D Expenses ending June 30, 2023 was $61.4 Million (a 10.38% increase compared to previous quarter)
- Twelve month trailing R&D Expenses increased by 47.15% year-over-year
Trailing R&D Expenses for the last four month:
30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
---|---|---|---|
$61.4 Million | $55.6 Million | $48.6 Million | $41.7 Million |
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical R&D Expenses of Design Therapeutics, Inc.
Most recent R&D Expensesof DSGN including historical data for past 10 years.Interactive Chart of R&D Expenses of Design Therapeutics, Inc.
Design Therapeutics, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $17.06 | $15.73 | – | – | – |
2022 | $14.26 | $14.3 | $11.3 | $8.76 | $48.61 |
2021 | $7.34 | $8.54 | $5.03 | $3.88 | $24.78 |
2020 | $2.71 | $1.91 | $1.06 | $0.38 | $6.06 |
2019 | – | – | – | – | $1.65 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology